We are proud to again partner with the United Mitochondrial Disease Foundation (UMDF). Together, we're funding research that gives hope to people living with mitochondrial diseases.
The 2026 grant round awarded US$500,000. This funding supports primary mitochondrial disease research.Â
We’re focused on two strategic goals:
- Advancing research from lab discovery to clinical care.
- Building the next generation of mitochondrial disease researchers.
We’re also looking for ideas in two key areas:
- Precision medicine approaches.
- Clinical trial readiness.

Key information
Important dates
Grant applications are now closed for this round.
Project start date: As early as September 2026, pending grant award agreement execution.